Anna G. Maione

Anna G. Maione has a diverse work experience spanning multiple industries. Anna G. is currently working at C4 Therapeutics, Inc. as the Director of Portfolio & Program Management since September 2022. Prior to this role, they held the position of Associate Director of Portfolio & Program Management at the same company from January 2021 to August 2022. Anna also worked as an Associate Program Manager of Strategic Alliances & Program Management at C4 Therapeutics, Inc. from September 2019 to January 2021.

Before joining C4 Therapeutics, Inc., Anna was a Senior Scientist & Contract Study Director at MatTek Corporation from September 2015 to September 2019. In this role, they collaborated with clients to design and conduct research studies, analyzed and interpreted data, and communicated results through reports and presentations.

Anna's earlier experience includes a postdoctoral scholar position at Tufts University from November 2014 to August 2015. Anna G. also pursued their Ph.D. at Tufts University, focusing on investigating the impaired wound healing functions of diabetic foot ulcer-derived fibroblasts using 3D models from September 2008 to October 2014.

Anna started their career in a different field, working as a data entry, billing, and customer service representative at ULTRA Scientific from June 2004 to August 2007. Anna G. also had brief internships as an office assistant at Applied Bio-Systems in June 2005 and as an intern dental assistant at William W. Sullivan, D.D.S. Dental Office in June 2005.

Overall, Anna has gained extensive experience in program and portfolio management, scientific research, and customer service throughout their career.

Anna G. Maione has an extensive education history. Anna G. earned their Bachelor of Arts (B.A.) degree in Biology with a specialization in Bioinformatics from Clark University, where they studied from 2004 to 2008. Following their undergraduate education, Anna attended the Tufts University School of Medicine from 2008 to 2014, where they acquired their Doctor of Philosophy (Ph.D.) degree in Cell/Cellular and Molecular Biology.

In addition to their academic achievements, Anna obtained a certification in Leadership for Drug Development Teams from the Tufts Center for the Study of Drug Development in October 2021.